1.
Roeten MSF, van Meerloo J, van Dijk SN, Kwidama Z, Jenkins G, Teachey DT, Devidas M, Loh ML, Kaspers GJL, Zweegman S, Jansen G, Horton TM, Cloos J. High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial. haematol [Internet]. 2020Sep.10 [cited 2025Feb.1];. Available from: https://haematologica.org/article/view/11922